BN Business News
Ku dar shirkad →

Ganacsi · 11/16/20261 daqiiqo akhris

Gumokimab (IL-17A) Akeso Waxaa Kaqalay NMPA Dhaqaaqka Ankylosing Spondylitis Active

Turjumaad otomaatig ah oo gudaha ah · Luqadda asalka ah ee isha

EDITORIAL ILLUSTRATIONGGanacsiBN
Illustration generated by Business News; it is not a source photograph.

Soo koobid

HONG KONG, 16 Noombi 2026 — Akeso, Inc. (9926. HK) waxaa la qoray ku guuray NMPA, dhaqaaqka medsiinada xagga Cina, ku guuray sNDA (New Drug Application) taas oo gumokimab, antybody monoclonal IL-17A oo Akeso waxaa ku jiro xubin, ku guuray dhaqaaqka ankylosing spondylitis active. Waxaa la qoray ku guuray dhaqaaqka ku guuray sNDA taas oo waxaa ku jiro xubin, ku guuray dhaqaaqka ankylosing spondylitis active.

Luqadda asalka ah ee isha: PR Newswire — Global News ReleasesFur bayaanka asalka ah →

Explore insights

Business insights →